TV 5382 (Abacavir sulfate and lamivudine 600 mg / 300 mg)
Pill imprint TV 5382 has been identified as Abacavir sulfate and lamivudine 600 mg / 300 mg.
Abacavir/lamivudine is used in the treatment of hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Abacavir/lamivudine 600 mg / 300 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about abacavir/lamivudine
- Other brands: Epzicom
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.